Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - Pyrosequencing (Sweden) makes appointments:

This article was originally published in Clinica

Executive Summary

Pyrosequencing (Uppsala, Sweden), a developer, manufacturer and commercialiser of complete solutions for rapid applied genetic analysis based on its proprietary technology, has appointed a new management team in connection with the completion of its forthcoming merger with Uppsala-based Personal Chemistry (PC). The new team will be chaired by Pyrosequencing's Jeff Bork, who will continue to serve in his current role as chairman and CEO. Hans Johansson, who currently serves as president at PC, will become president and COO, whilst Mats-Olof Wallin and Marten Winge will continue their responsibilities as CFO and vice-president of marketing, respectively. Scott Carr, who currently serves as head of PC's US sales company, will become president of the merged US subsidiaries, and Jon-Sverre Schanche, who currently serves as vice-president of R&D at PC, will continue to serve in this capacity at the new company. The merger is expected to be completed after Pyrosequencing's AGM on September 25.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063465

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel